CSHL 2020 Protein Homeostasis in Health and Disease
Project Number1R13AG066400-01
Contact PI/Project LeaderSTEWART, DAVID J.
Awardee OrganizationCOLD SPRING HARBOR LABORATORY
Description
Abstract Text
Cold Spring Harbor Laboratory Conference on
Protein Homeostasis in Health and Disease
April 21 – 25, 2020
ABSTRACT
This proposal is a request for financial support for a meeting on PROTEIN HOMEOSTASIS IN
HEALTH AND DISEASE to be held at Cold Spring Harbor Laboratory from April 21 – 25, 2020.
This meeting is the premier international forum for presentation of new results in this area, and
is attended by representatives from virtually every major laboratory in the field. The explosion of
new information on how the folded state of proteins is acquired and maintained in vivo and the
relevance of this process to healthy aging and risk for diseases of neurodegeneration, cancer,
and metabolism guarantees an excitement and urgency of this meeting. Because of the recent
developments on stress signaling in aging and disease, we will open the meeting with this new
session followed the next day with a session on protein aggregation in aging and
neurodegenerative diseases and then closing the meeting with a session on correcting
proteostasis in aging and disease. Additional sessions will address the relationship between
protein synthesis, folding, translocation and degradation by discussing the molecular
mechanisms of chaperone function, degradative mechanisms and on spatial quality control and
organellar proteostasis. The meeting will also introduce another new session on stress
granules and phase transitions that has brought many new concepts on stress physiology,
regulatory biology and novel forms of macromolecular interaction. These fundamental questions
are at the heart of biology of proteostasis that will be complemented by the sessions on aging
and proteostasis failure in diseases of protein misfolding including Alzheimer's disease, ALS,
Parkinson's disease and Huntington's disease. The themes of aging, proteostasis failure, and
diseases of protein misfolding are well integrated throughout the meeting, and emerging
principles on protein client interactions and alternate protein conformations will be
predominantly displayed. The diverse protein quality control strategies used by compartments
of the cell to ensure the integrity of the secretory and organellar pathways during times of
protein folding stress will be represented by emerging topics on spatial quality control within a
cell. The field of heat shock proteins and molecular chaperones has grown exponentially and
draws interest not only from traditional scientific disciplines in the basic sciences but also from
diverse areas of biomedical research including neurodegenerative disease, infectious diseases,
cancer, heart disease and aging. The meeting will have eight lecture sessions, two poster
sessions, two rapid-fire presentation sessions, and a panel discussion on scientific publishing.
The sessions include: 1) Integrative stress signaling in aging and disease, 2) Chaperone
mechanisms I, 3) Protein aggregation in aging and neurodegenerative diseases, 4) Clearance
mechanisms, 5) Chaperone mechanisms II, 6) Stress granules and phase transitions, 7)
Organellar proteostasis and spatial quality control, and 8) Correcting proteostasis in aging and
disease. Each session will consist of eight to nine oral presentations and will be chaired by an
invited speaker. Generally, two speakers will be pre-invited per session with the remainder to be
selected from submitted abstracts, thus ~60-65% of speakers will be from submitted abstracts
to ensure balance of junior investigators, women and all forms of diversity. As well, we will have
two rapid fire sessions, each with ten-2 min. talks to increase the visibility from the poster
sessions. This balance of talks allows the meeting to feature presentations by leading
scientists, to be responsive to exciting new developments, and to encourage diverse
participation that recognizes new investigators.
Public Health Relevance Statement
Cold Spring Harbor Laboratory Conference on
Protein Homeostasis in Health and Disease
April 21 – 25, 2020
PROJECT NARRATIVE
Proteins are composed of polymers of amino acids (or polypeptides) and execute essential
tasks in all living organisms. Protein function is critically dependent on the folding of their
constituent polypeptides into active three-dimensional objects through the interactions of
molecular chaperones. Protein homeostasis is achieved by balanced synthesis, folding,
translocation and degradation of proteins. Experimental evidence accumulated in the recent
past has revealed that failure of this process (protein misfolding) in aging leads to some of the
most devastating diseases affecting humanity. The latter include common neurodegenerative
disorders, such as Parkinson's Disease and Alzheimer's Disease, common metabolic disorders
such as Diabetes Mellitus and a host of other conditions liked to the aging process. The Cold
Spring Harbor Meeting on Protein Homeostasis in Health and Disease brings together
experts in diverse aspects of protein folding, the cellular response to protein misfolding and
diseases and therapeutic approaches for age-associated diseases of protein conformation. As
such it serves as the premier clearinghouse for ideas on how to eventually translate the basic
discoveries in the area to future treatments of recalcitrant diseases.
No Sub Projects information available for 1R13AG066400-01
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 1R13AG066400-01
Patents
No Patents information available for 1R13AG066400-01
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 1R13AG066400-01
Clinical Studies
No Clinical Studies information available for 1R13AG066400-01
News and More
Related News Releases
No news release information available for 1R13AG066400-01
History
No Historical information available for 1R13AG066400-01
Similar Projects
No Similar Projects information available for 1R13AG066400-01